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In normal rat kidney cells protein tyrosine phosphatases (PTPases) play a role in attaining density-dependent growth arrest after stimulation with 
mitogens. The PTPase inhibitor sodium orthovanadate prevents density-dependent growth inhibition of EGF-treated cells and mimicks in that 
respect he action of TGFB and retinoic acid. However, enhanced PTPase activity is not obligatory for maintaining cells in a density-arrested state. 
In contrast to TGFB and retinoic acid, vanadate is unable to restimulate density-inhibited cells, indicating that different mechanisms are operating. 
Yet, vanadate is strongly potentiating the effect of low concentrations of TGFB but not of retinoic acid, implicating that tyrosine phosphorylation 
is linked to TGF/I action and that PTPase may represent a negative control element in the TGF/I signaling pathway. 
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1. INTRODUCTION induced proliferation is limited by the level of EGF 
receptor expression (van Zoelen et al., submitted). 
Normal rat kidney (NRK) cells have been widely Recently we investigated the influence of the protein 
used as a model system to study the role of polypeptide tyrosine phosphatase (PTPase) inhibitor orthovanadate 
growth factors in the process of oncogenic transforma- on the mitogenic stimulation of serum-deprived quies- 
tion [1,2]. Stimulation of confluent NRK cells, made cent NRK cells and its effect on density-dependent 
quiescent following serum-deprivation, by EGF induces growth arrest [lo]. It was shown that in contrast to 
cells to undergo one additional round of cell division. TGFB, vanadate hardly increased the proportion of 
After completion of this cell cycle proliferation stops as serum-deprived quiescent cells which entered S-phase 
a result of density-dependent growth inhibition. Such after stimulation with an optimal dosis of EGF. How- 
density-dependent growth arrest can be prevented by ever, the effect of low doses of the growth factor was 
adding modulating agents like TGF/? or retinoic acid strongly potentiated by vanadate, indicating that it is 
(RA). Moreover, these agents are able to restimulate able to optimize the growth factor signal in those cells 
density-inhibited EGF-treated cells, thereby inducing that are capable of generating a signal sufficient to in- 
phenotypical characteristics of transformation [2]. Nei- duce proliferation. Moreover, in EGF-stimulated cells 
ther TGFB nor RA by itself has any growth-stimulatory the density-dependent inhibition of growth was found 
effect on NRK cells and it is believed that the action of to be prevented by the addition of vanadate. In the 
TGF/? and RA involves the modulation of EGF recep- latter respect he action of vanadate mimicked the effect 
tor levels by transcriptional activation of the gene [3-61. of TGFj? and RA. Obviously NRK cells possess PTPase 
In several cell lines including NRK, receptor levels have activity which can regulate signals transmitted by tyro- 
been shown to decrease with increasing cell densities sine kinase associated receptors and thus potentially 
and a causal relationship with density-dependent plays a role in the process of phenotypical transforma- 
growth inhibition has been suggested [7-91. Indeed we tion. In agreement with this suggestion membrane 
could show that the ability of EGF to induce prolifera- PTPase activity of dense contact-inhibited Swiss 3T3 
tion in NRK cells is a direct function of the EGF recep- cells was shown to be increased &fold on average when 
tor density and that in density-arrested cultures EGF compared to low-density proliferating cells [ 111. 
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Based on these observations it was hypothesized that, 
whereas TGFB and RA upregulate EGF receptor densi- 
ties and thus enhance incoming signals, vanadate in 
contrast does not amplify the initial signal, but prevents 
its down regulation resulting in prolonged receptor acti- 
vation. This model predicts that after down regulation 
of EGF receptor densities, i.e. in density-inhibited cells, 
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vanadate is unable to restimulate proliferation in con- 
trast to TGFB and RA. In the present study we put this 
hypothesis to the test by comparing the effects of vana- 
date, TGF/? and RA on density-inhibited NRK cells. 
2. MATERIALS AND METHODS 
2.1. Cell culture 
Cell culture procedures and measurement of [‘Hlthymidine incorpo- 
ration were performed as described earlier [1,10,12]. Normal rat kid- 
ney cells, clone 49F, were plated at a density of 2.5 x lo4 11.8 cm* in 
24 well plates (Costar, Cambridge MA, USA) in bicarbonate-buffered 
Dulbecco’s modified Eagle’s medium (DMEM, Flow Laboratories, 
Irvine, Scotland), supplemented with 10% newborn calf serum 
(Hyclone, Logan). After incubation for 4 days cells had reached con- 
fluency, and the medium was exchanged for 1 ml of a 1: 1 bicarbonate- 
buffered mixture of Dulbecco’s modified Eagle’s medium and Ham’s 
F12 medium (Flow Laboratories), supplemented with 30 nM Na,SeO, 
(ICN, Plainview NY, USA) and 10 &ml human transferrin (Sigma, 
St. Louis MO, USA). After 72 hr in this serum-free medium, the cells 
were stimulated with EGF (5 &ml) and insulin (5 &ml) in 0.1 ml 
of binding buffer (DMEM containing 50 mM N, N-bis(2-hydroxy- 
ethyl)-2-amino-ethane sulphonic acid (Sigma) and 0.1% bovine serum 
albumin (Sigma), pH 6.8). Fourty-eight hours after mitogenic stimula- 
tion, when cell growth had stopped because of density-dependent 
growth inhibition, cells were treated again with growth factors and/or 
vanadate. Unless otherwise indicated modulating agents were rou- 
tinely added in triplicate in the following concentrations: TGFB,, 2 
@ml, RA 50 ng/ml. [HJThymidine ([‘H]TdR) incorporation was 
measured between 4 and 17 hrs after restimulation. [3H]TdR (0.5 BCi, 
43 CYmmol, Amersham, Buckinghamshire, UK) was added in 0.1 ml 
Ham’s F12 medium. After the indicated time interval cells were 
washed four times with ice-cold phosphate-buffered saline and incu- 
bated for 15 min with 0.5 ml methanol at room temperature. The 
methanol was removed and the wells were allowed to air dry. The cells 
were then solubilized in 1 ml 0.5 N NaOH and [“H]TdR incorporation 
was measured by liquid scintillation counting. [‘H]TdR incorporation 
was measured in triplicate. Sample standard deviation was always less 
than 10%. 
2.2. Vanadate solutions and growth factors 
Stock solutions of 25 mM sodium orthovanadate (Na,VO,, Sigma) 
were either prepared fresh in distilled water without any further pre- 
cautions or were adjusted to pH 10, heated ad readjusted to pH 10 as 
described [13]. The latter preparation could be stored at 4°C for 
several months without any loss in activity. Transforming growth 
factor-p, was purified from outdated human blood platelets as de- 
scribed [14]. Receptor grade EGF was obtained from Collaborative 
Research (Waltham MA, USA), retinoic acid and insulin (bovine 
pancreas) were obtained from Sigma (St. Louis, MO). 
3. RESULTS 
3.1. Influence of vanadate on density-inhibited NRK cells 
We compared the effects of the PTPase inhibitor va- 
nadate and modulating factors like TGFjI and RA on 
NRK cells after reaching the density-inhibited state. 
Confluent NRK cells were kept quiescent by serum dep- 
rivation for three days and consecutively stimulated by 
EGF and insulin. A fraction of the cells (approx. 40% 
[ 1,2]) respond by completing one round of cell division, 
after which (48 h) proliferation stops because of density- 
dependent growth inhibition [l,lO], inspite of the pres- 
ence of EGF and insulin. Cells are restimulated then by 
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adding TGFB, RA or vanadate (Fig. 1). In accordance 
with earlier studies [I ,2] TGF/3 and RA are able to 
induce DNA synthesis in density-inhibited cells. How- 
ever, in contrast to these effecters vanadate by itself 
increases [3H]TdR incorporation only to a very limited 
extent. This slight stimulatory effect is reached at a 
vanadate concentration as low as IO ,uM (Fig. 2), and 
no further stimulation can be observed at higher con- 
centrations. 
3.2. Influence of vanadate on restimulation of density- 
inhibited cells by TGFB and RA 
In the next series of experiments we investigated 
whether vanadate is able to modulate the growth induc- 
ing activities of TGF/? and RA. Initially we only used 
optimal concentrations of these effecters (Fig. 2). Under 
these conditions there appeared to be a slight stimula- 
tory effect of vanadate on cumulative [3H]TdR incorpo- 
ration, which was to be largely additive. The effect was 
maximal at concentrations varying between IO-25 PM. 
In contrast, at higher concentrations an inhibitory effect 
was observed. The latter effect is in accordance with 
earlier findings showing similar inhibitory effects of 
higher concentrations of vanadate on mitogenic stimu- 
lation of NRK cells, prevention of density-dependent 
growth inhibition induced by several growth factors and 
induction of anchorage independent growth [IO]. 
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Fig. 1. Stimulation of density-inhibited NRK cells by vanadate and 
growth factors. Quiescent cells are stimulated with insulin and EGF. 
After 48 h proliferation has stopped because of density-dependent 
growth inhibition. Cells are restimulated then with vanadate and 
growth factors. Cumulative t3H]TdR incorporation is measured 5-17 
h after the latter additions. Stimulation is expressed as -fold increase 
over the control to which only binding buffer is added. The bars 
represent he mea&standard error of five independent experiments. 
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Fig. 2. Concentration dependence of the influence of vanadate on the stimulation of density-inhibited cells by growth factors. Cells are restimulated 
with increasing concentrations of vanadate in the presence of saturating concentrations of TGFB (0) or RA (A). In the control experiment (x) no 
growth factor is added. Conditions are as described in the legend to Fig. 1. A representative experiment is shown. The optimal concentration of 
vanadate varied from experiment o experiment between l&25 ,uM. S.D.‘s of triplicate determinations were always < 10%. 
Remarkably, in contrast to the absence of any appre- 
ciable effects of vanadate under optimal growth factor 
conditions, vanadate strongly potentiated the effect of 
TGFB when present at suboptimal concentrations. The 
dose-response curve for the effect of the modulating 
agent was shifted to much lower concentrations in the 
presence of 25 @vI vanadate. In the absence of vanadate 
half-maximal stimulation occurred at approx. 0.6 rig/ml 
TGFj?, whereas vanadate lowered this concentration 
approx. 10 times (Fig. 3A). In contrast, no potentiating 
effects were found in case of restimulation with RA 
(Fig. 3B). 
4. DISCUSSION 
The phosphorylation of tyrosyl residues plays a key 
role in the regulation of growth and differentiation. 
Also in the regulation of density-dependent growth inhi- 
bition of NRK cells, which is used as a model for pheno- 
typical transformation, the action of receptor tyrosine 
kinases has been shown to be of primary importance [2]. 
Since a regulatory role for PTPases have been suggested 
in counteracting the effects of tyrosine kinases [15,16], 
we decided to study the role of PTPase activities in the 
transformation of NRK cells by using the inhibitor so- 
dium orthovanadate. In accordance with an earlier re- 
port of Klarlund [17], we recently demonstrated that 
vanadate was able to transform NRK cells: It mimicked 
the action of TGFjI and RA in the prevention of den- 
sity-dependent growth inhibition [lo]. Similarly to 
TGFj3 and RA, vanadate by itself hardly influenced cell 
growth, but required the additional presence of EGF. 
Also, anchorage-independent growth in presence of 
EGF and insulin could be induced by TGF/3, RA as well 
as vanadate. These results suggest that modulating 
agents such as TGFB and RA as well as PTPase inhib- 
itors such as vanadate influence the EGF signaling 
pathway similarly and that PTPase(s) play a regulatory 
role in density-dependent growth inhibition. In agree- 
ment with the latter suggestion membrane PTPase ac- 
tivity of dense contact-inhibited Swiss 3T3 cells was 
shown to be increased 8-fold on average when com- 
pared to low-density proliferating cells [l 11. 
We now show, that although PTPase activity may be 
obligatory for attaining density-dependent growth inhi- 
bition, it certainly is not necessary for maintaining den- 
sity arrest. In contrast to TGFB and RA, vanadate by 
itself is unable to restimulate density-inhibited cells. 
Thus its mechanism of action in the prevention of den- 
sity-dependent growth arrest appears to be different 
from that of TGFj? and RA. It can be hypothesized that, 
whereas TGFB and RA are supposed to upregulate re- 
ceptor densities and thus to enhance incoming signals, 
vanadate in contrast doesnot amplify the initial signal, 
but prevents its down regulation (Fig. 4). In EGF-stim- 
ulated cells vanadate may act by inhibiting a PTPase 
which is responsible for the dephosphorylation of auto- 
phosphorylated EGF receptors or tyrosylphosphoryl- 
ated substrates downstream in the signal transduction 
pathway. As a consequence the feedback regulation of 
the signal is impaired, resulting in a prolonged stimula- 
tory effect of EGF in sensitive cells. In density-inhibited 
cells the EGF receptor level is down- regulated to a very 
low level [8] and the EGF signaling pathway is no longer 
sufficient for growth stimulation, not even in the pres- 
ence of vanadate. 
Remarkably, although the effect of vanadate by itself 
on density-inhibited NRK cells was negligable, it poten- 
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Fig. 3. Influence of vanadate on the dossresponse curve of TGFB and RA for the stimulation of density-inhibited cells. Cells are restimulated 
with increasing concentrations of TGFB (A) and RA (B) in the presence of 0 (0) and 25 (x),uM vanadate. Conditions are as described in the legend 
to Fig. 1. 
tiated significantly the effect of low concentrations of 
TGFB: half-maximal stimulation of DNA synthesis oc- 
curred at lo-fold lower concentrations of TGF/I in the 
presence of vanadate. This result suggests that PTPase 
activity acts as a negative control element in the TGF/I 
signaling pathway and conversely that tyrosine phos- 
phorylation plays a positive role somewhere in the 
transduction of the signal. The intracellular signaling 
pathway triggered by TGF/3 is almost completely un- 
known [18] and no tyrosine phosphorylation has been 
linked to TGFjI action up to now [18,19]. Recent clon- 
ing of one of the primary TGFj? binding proteins func- 
tioning as a transmembrane signaling receptor, the 
TGF/3 type II receptor, revealed evidence for the pres- 
ence of a functional intracellular protein kinase domain 
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[20]. However, its sequence fitted better with the serine/ 
threonine kinase consensus than with the tyrosine ki- 
nase concensus [18,20], making a direct regulatory 
mechanism through dephosphorylation of the receptor 
itself or its substrates by PTPase activity less likely. 
Consequently, the involvement of tyrosine phosphoryl- 
ation in the TGFjI action, which is suggested in the 
present study, may be localized more downstream in the 
signal transduction pathway. On the other hand the 
activin receptor, which is related to the TGFB receptor, 
has been shown to have a dual specificity as it phospho- 
rylates both Ser/Thr and Tyr residues [21]. 
By comparing the effect of vanadate on TGFB and 
RA action, it can be concluded that it is specific for the 
signal transduction pathway triggered by TGFB and 
Volume 322. number 1 FEBS LETTERS May 1993 
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Fig. 4. Signal amplification by TGFB and vanadate. In this model TGFfi acts by increasing the level of EGF receptor and thus amplifies the incoming 
signal. Vanadate, on the other hand, inhibits the PTPase(s) responsible for the dephosphorylation ofautophosphorylated EGF receptor and receptor 
substrates and thus prevents downregulation of the signal. 
not an aspecific effect associated with weak growth 
stimulator-y signals in general. Although TGFj3 and RA 
have comparable effects on density-inhibited NRK cells 
and both act by increasing the EGF receptor density in 
this cell line, no shift of the dose-response curve of RA 
could be observed. To our knowledge this is the first 
biological difference observed in the action of TGFB 
and RA in the NRK model system. 
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